Atlas Trials

European Organisation for Research and Treatment of Cancer - EORTC

352 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch European Organisation for Research and Treatment of Cancer - EORTC

RecordFirmDate
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT00030784)European Organisation for Research and Treatment of Cancer - EORTC2001-11-01
Radiation Therapy in Treating Patients With Aggressive Fibromatoses (NCT00030680)European Organisation for Research and Treatment of Cancer - EORTC2001-11-01
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium (NCT00028756)European Organisation for Research and Treatment of Cancer - EORTC2001-10-01
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer (NCT00030511)European Organisation for Research and Treatment of Cancer - EORTC2001-10-01
Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy (NCT00028704)European Organisation for Research and Treatment of Cancer - EORTC2001-10-01
Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer (NCT00027794)European Organisation for Research and Treatment of Cancer - EORTC2001-09-01
R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy (NCT00028873)European Organisation for Research and Treatment of Cancer - EORTC2001-09-01
MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00027781)European Organisation for Research and Treatment of Cancer - EORTC2001-08-01
Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors (NCT00027677)European Organisation for Research and Treatment of Cancer - EORTC2001-08-01
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx (NCT00025298)European Organisation for Research and Treatment of Cancer - EORTC2001-07-01
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer (NCT00022620)European Organisation for Research and Treatment of Cancer - EORTC2001-06-01
BCG With or Without Mitomycin in Treating Patients With Bladder Cancer (NCT00023842)European Organisation for Research and Treatment of Cancer - EORTC2001-06-01
Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer (NCT00022594)European Organisation for Research and Treatment of Cancer - EORTC2001-05-01
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer (NCT00022191)European Organisation for Research and Treatment of Cancer - EORTC2001-05-01
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain (NCT00020839)European Organisation for Research and Treatment of Cancer - EORTC2001-04-01
Assessing Quality of Life of Patients With Stomach Cancer (NCT00020826)European Organisation for Research and Treatment of Cancer - EORTC2001-04-01
Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer (NCT00021112)European Organisation for Research and Treatment of Cancer - EORTC2001-04-01
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer (NCT00021450)European Organisation for Research and Treatment of Cancer - EORTC2001-04-01
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia (NCT00017108)European Organisation for Research and Treatment of Cancer - EORTC2001-03-01
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer (NCT00017095)European Organisation for Research and Treatment of Cancer - EORTC2001-03-01
Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer (NCT00017277)European Organisation for Research and Treatment of Cancer - EORTC2001-03-01
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer (NCT00014612)European Organisation for Research and Treatment of Cancer - EORTC2001-02-01
E7070 in Treating Patients With Stage IV Melanoma (NCT00014625)European Organisation for Research and Treatment of Cancer - EORTC2001-02-01
Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck (NCT00017498)European Organisation for Research and Treatment of Cancer - EORTC2001-02-01
Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer (NCT00016211)European Organisation for Research and Treatment of Cancer - EORTC2001-02-01
Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva (NCT00014599)European Organisation for Research and Treatment of Cancer - EORTC2001-02-01
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor (NCT00014313)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma (NCT00014326)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor (NCT00685828)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00014300)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium (NCT00014274)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer (NCT00014586)European Organisation for Research and Treatment of Cancer - EORTC2001-01-01
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer (NCT00010153)European Organisation for Research and Treatment of Cancer - EORTC2000-11-01
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors (NCT00006477)European Organisation for Research and Treatment of Cancer - EORTC2000-09-01
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer (NCT00006479)European Organisation for Research and Treatment of Cancer - EORTC2000-09-01
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma (NCT00006357)European Organisation for Research and Treatment of Cancer - EORTC2000-08-01
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer (NCT00006356)European Organisation for Research and Treatment of Cancer - EORTC2000-08-01
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00006354)European Organisation for Research and Treatment of Cancer - EORTC2000-08-01
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00006353)European Organisation for Research and Treatment of Cancer - EORTC2000-07-01
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma (NCT00006249)European Organisation for Research and Treatment of Cancer - EORTC2000-06-01
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT00006122)European Organisation for Research and Treatment of Cancer - EORTC2000-06-01
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00006351)European Organisation for Research and Treatment of Cancer - EORTC2000-06-01
Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy (NCT00006121)European Organisation for Research and Treatment of Cancer - EORTC2000-05-01
Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer (NCT00006082)European Organisation for Research and Treatment of Cancer - EORTC2000-05-01
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer (NCT00006230)European Organisation for Research and Treatment of Cancer - EORTC2000-05-01
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract (NCT00006026)European Organisation for Research and Treatment of Cancer - EORTC2000-05-01
Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer (NCT00005980)European Organisation for Research and Treatment of Cancer - EORTC2000-04-01
Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer (NCT00005868)European Organisation for Research and Treatment of Cancer - EORTC2000-03-01
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme (NCT00005826)European Organisation for Research and Treatment of Cancer - EORTC2000-03-01
Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer (NCT00008034)European Organisation for Research and Treatment of Cancer - EORTC2000-02-01
Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00005055)European Organisation for Research and Treatment of Cancer - EORTC2000-01-01
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00004886)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer (NCT00005053)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Vaccine Therapy in Treating Patients With Primary Stage II Melanoma (NCT00005052)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00005061)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura (NCT00004920)European Organisation for Research and Treatment of Cancer - EORTC1999-11-01
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed (NCT00004254)European Organisation for Research and Treatment of Cancer - EORTC1999-11-01
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00004937)European Organisation for Research and Treatment of Cancer - EORTC1999-10-01
Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00004151)European Organisation for Research and Treatment of Cancer - EORTC1999-09-01
Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00006352)European Organisation for Research and Treatment of Cancer - EORTC1999-09-01
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia (NCT00004128)European Organisation for Research and Treatment of Cancer - EORTC1999-09-01
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer (NCT00004884)European Organisation for Research and Treatment of Cancer - EORTC1999-07-01
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer (NCT00004099)European Organisation for Research and Treatment of Cancer - EORTC1999-07-01
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer (NCT00004885)European Organisation for Research and Treatment of Cancer - EORTC1999-07-01
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients (NCT00003938)European Organisation for Research and Treatment of Cancer - EORTC1999-06-01
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma (NCT00004179)European Organisation for Research and Treatment of Cancer - EORTC1999-05-01
CHS 828 in Treating Patients With Solid Tumors (NCT00003979)European Organisation for Research and Treatment of Cancer - EORTC1999-04-01
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00003888)European Organisation for Research and Treatment of Cancer - EORTC1999-04-01
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma (NCT00003916)European Organisation for Research and Treatment of Cancer - EORTC1999-04-01
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer (NCT00003941)European Organisation for Research and Treatment of Cancer - EORTC1999-04-01
BIBX 1382 in Treating Patients With Solid Tumors (NCT00003980)European Organisation for Research and Treatment of Cancer - EORTC1999-02-01
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome (NCT00003984)European Organisation for Research and Treatment of Cancer - EORTC1999-02-01
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed (NCT00003803)European Organisation for Research and Treatment of Cancer - EORTC1999-02-01
Quality-of-Life Assessment in Patients With Ovarian Cancer (NCT00003772)European Organisation for Research and Treatment of Cancer - EORTC1999-01-01
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma (NCT00003728)European Organisation for Research and Treatment of Cancer - EORTC1998-12-01
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia (NCT00003729)European Organisation for Research and Treatment of Cancer - EORTC1998-12-01
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer (NCT00003730)European Organisation for Research and Treatment of Cancer - EORTC1998-12-01
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia (NCT00003758)European Organisation for Research and Treatment of Cancer - EORTC1998-12-01
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors (NCT00003731)European Organisation for Research and Treatment of Cancer - EORTC1998-12-01
Combination Chemotherapy in Treating Men With Germ Cell Cancer (NCT00003643)European Organisation for Research and Treatment of Cancer - EORTC1998-10-01
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma (NCT00005584)European Organisation for Research and Treatment of Cancer - EORTC1998-10-01
Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00003642)European Organisation for Research and Treatment of Cancer - EORTC1998-10-01
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00003640)European Organisation for Research and Treatment of Cancer - EORTC1998-09-01
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00003636)European Organisation for Research and Treatment of Cancer - EORTC1998-09-01
KRN7000 in Treating Patients With Solid Tumors (NCT00003985)European Organisation for Research and Treatment of Cancer - EORTC1998-09-01
Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome (NCT00003681)European Organisation for Research and Treatment of Cancer - EORTC1998-08-01
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT00003589)European Organisation for Research and Treatment of Cancer - EORTC1998-08-01
ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma (NCT00003989)European Organisation for Research and Treatment of Cancer - EORTC1998-06-01
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors (NCT00003304)European Organisation for Research and Treatment of Cancer - EORTC1998-04-01
E7070 in Treating Patients With Solid Tumors (NCT00003981)European Organisation for Research and Treatment of Cancer - EORTC1998-04-01
E7070 in Treating Patients With Solid Tumors (NCT00003976)European Organisation for Research and Treatment of Cancer - EORTC1998-03-01
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00003279)European Organisation for Research and Treatment of Cancer - EORTC1998-03-01
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00003287)European Organisation for Research and Treatment of Cancer - EORTC1998-03-01
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer (NCT00053807)European Organisation for Research and Treatment of Cancer - EORTC1998-02-01
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer (NCT00003267)European Organisation for Research and Treatment of Cancer - EORTC1998-02-01
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus (NCT00003321)European Organisation for Research and Treatment of Cancer - EORTC1998-02-01
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT00003212)European Organisation for Research and Treatment of Cancer - EORTC1998-01-01
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer (NCT00003209)European Organisation for Research and Treatment of Cancer - EORTC1997-12-01
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count (NCT00003805)European Organisation for Research and Treatment of Cancer - EORTC1997-11-01
Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia (NCT00003148)European Organisation for Research and Treatment of Cancer - EORTC1997-10-01
← Previous Next →

Track European Organisation for Research and Treatment of Cancer - EORTC automatically

Every clearance here is in the API, with alerts when new ones post.